Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Cancer|August 12, 2003
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcomaCaroline Laverdiere, E Anders Kolb, Jeffrey G Supko, et al.Clinical Nutrition (Edinburgh, Scotland)|January 15, 2019
Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohortElena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.Leukemia|December 18, 2009
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000)L B Silverman, K E Stevenson, J E O'Brien, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT CohortElena J Ladas, Traci M Blonquist, Maneka Puligandla, et al.Pediatric Blood & Cancer|June 8, 2018
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001Uma H Athale, Maneka Puligandla, Kristen E Stevenson, et al.Blood Advances|January 26, 2021
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohortSong Yao, Qianqian Zhu, Peter D Cole, et al.Pediatric Blood & Cancer|January 11, 2018
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemiaM L Sulis, T M Blonquist, K E Stevenson, et al.Pediatric Blood & Cancer|November 2, 2017
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001Justine M Kahn, Peter D Cole, Traci M Blonquist, et al.Pediatric Blood & Cancer|March 22, 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001Uma H Athale, Yael Flamand, Traci Blonquist, et al.JAMA Network Open|April 27, 2019
Molecular Profiling of Hard-to-Treat Childhood and Adolescent CancersFida Khater, Stephanie Vairy, Sylvie Langlois, et al.Pageof 11